Overall, GvHD is a rare<unk> , given that this<unk>  can only develop after a stem cell transplant is performed, and only a small fraction of people undergo stem cell transplants. However, amongst those who do undergo stem cell transplants, the incidence of GvHD is high (35-50%). The incidence of GvHD is estimated to be 9.5x10-7 per 100,000 cases. There are approximately 5500 total cases annually. Patients of all age groups may develop GvHD, but it occurs more commonly in older persons who receive stem cells from female donors. GvHD affects men more commonly than women. There is no racial predilection to GvHD. The incidence of GvHD is not directly correlated with age, as the<unk>  is an iatrogenic condition that occurs after a transplant, rather than a natural<unk> .
Graft-versus-host disease epidemiology and demographics
Cardiac allograft vasculopathy epidemiology and demographics
Wegeners granulomatosis epidemiology and demographics
Hamman-Rich syndrome epidemiology and demographics
Lymphomatoid granulomatosis epidemiology and demographics
Sarcoidosis epidemiology and demographics
Drug allergy epidemiology and demographics
Multi-drug-resistant tuberculosis epidemiology and demographics